Product Information
ONDANSETRON HCL 8 MG TABLET is a generic product labeled by Natco Pharma USA LLC, priced at $0.0781 per EA under NDC 69339017201. Its NADAC has been published 35 times since Feb 4, 2026.
FDA first approved this application on Jun 25, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
8 mg/1
Manufacturer
Natco Pharma USA LLCNDC
69339017201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ONDANSETRON HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077851FDA Approved
6/25/2007
TE Code
AB
On Market Since
10/24/2022
Pharmacological Classes
Price Statistics
The NADAC for ONDANSETRON HCL 8 MG TABLET has been published 35 times since Feb 4, 2026, and over the history we have for it it has declined 17.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0781 per EA |
|---|---|
| All-time high | $0.0949 (Feb 11, 2026) |
| All-time low | $0.0781 (Sep 23, 2026) |
| 52-week high | $0.0949 |
| 52-week low | $0.0781 |
| Median price | $0.0895 |
| Average price | $0.0877 |
| Largest weekly change | -4.0% (Jul 22, 2026) |
| Weeks tracked | 35 |
| Tracking since | Feb 4, 2026 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Natco Pharma USA LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ondansetron market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-3 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ONDANSETRON HCL 8 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ONDANSETRON HCL 8 MG TABLET, manufactured by Natco Pharma USA LLC, is $0.0781 per EA (NDC 69339017201), effective Sep 30, 2026.
How has the price of ONDANSETRON HCL 8 MG TABLET changed over time?
Over the history we have for it, the NADAC for ONDANSETRON HCL 8 MG TABLET has declined 17.7%. It has been tracked across 35 weekly CMS publications since Feb 4, 2026.
What are the highest and lowest recorded NADAC prices for ONDANSETRON HCL 8 MG TABLET?
Since Feb 4, 2026, the NADAC for ONDANSETRON HCL 8 MG TABLET has ranged from a low of $0.0781 (Sep 23, 2026) to a high of $0.0949 (Feb 11, 2026), with a median of $0.0895 per EA.
Are there cheaper alternatives to ONDANSETRON HCL 8 MG TABLET?
8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ONDANSETRON HCL 8 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ONDANSETRON HCL 8 MG TABLET?
ONDANSETRON HCL 8 MG TABLET (NDC 69339017201) is labeled by Natco Pharma USA LLC, and CMS classifies it as a generic product.